aod9604 fda approved AOD 9604 Peptide for Fat Loss: Does It Work? aod9604 fda AOD-9604-10MG

In one experiment, researchers investigated the effects of 5-amino-1MQ on HeLa cells, a well-known cancer cell line

Diabetes, Obesity & Metabolism

The inclusion of this compound in research protocols introduces a potent variable for investigating anti-inflammatory signaling and the prevention of muscle catabolism at the cellular level

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007